The dyspnea target: Can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease?

Current Opinion in Supportive and Palliative Care

Volumn 4, Issue 2, 2010, Pages 92-96

  Horton, Robert ^a   Rocker, Graeme ^b   Currow, David ^c  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Opioids

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; HOSPITALIZATION; HUMAN; PSYCHOLOGICAL ASPECT; SELF CONCEPT; TREATMENT OUTCOME;

ANALGESICS, OPIOID; DYSPNEA; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF EFFICACY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77953855131     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e3283392788     Document Type: Article

References (44)

1. Elkington H, White P, Addington-Hall J, et al. The last year of life of COPD: a qualitative study of symptoms and services. Respir Med 2004; 98:439-445.
2. Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc 2000; 48 (5 Suppl):S146-S153.
3. Simpson AC, Rocker GM. Advanced chronic obstructive pulmonary disease: impact on informal caregivers. J Palliat Care 2008; 24:49-54.
4. Seamark DA, Blake SD, Seamark CJ, Halpin DM. Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers. An interpretative phenomenological analysis. Palliat Med 2004; 18:619-625.
5. Currow DC, Ward A, Clark K, et al. Caregivers for people with end-stage lung disease: characteristics and unmet needs in the whole population. Int J Chron Obstruct Pulmon Dis 2008; 3:753-762.
6. Booth S, Silvester S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care 2003; 1:337-344.
7. Rocker GM, Sinuff T, Horton R, Hernandez P. Advanced chronic obstructive pulmonary disease: innovative approaches to palliation. J Palliat Med 2007; 10:783-797.
8. Abramson MJ, Crockett AJ, Frith PA, McDonald CF. COPDX: an update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. Med J Aust 2006; 184:342-345.
9. O'Donnell DE, Aaron S, Bourbeau J, et al. State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J 2004; 11 (Suppl B):7B-59B.
10. Rocker GM, Young J, Horton R. Using opioids to treat dyspnoea in advanced COPD: a survey of Canadian clinicians. Chest 2008; 134:s29001.
11. Dyspnoea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999; 159: 321-340.
12. Rocker G, Horton R, Currow D, et al. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids. Thorax 2009; 64:910-915.
13. Mercadante S. Predictive factors and opioid responsiveness in cancer pain. Eur J Cancer 1998; 34:627-631. (Pubitemid 28218935)
14. Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. Part 1: Clinical considerations. J Pain Symptom Manage 2001; 21:144-150.
15. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 1990; 43:273-286.
16. Currow DC, Plummer J, Frith P, Abernethy AP. Can we predict which patients with refractory dyspnoea will respond to opioids? J Palliat Med 2007; 10:1031-1036.
17. Abernethy AP, Wheeler JL. Total dyspnoea. Curr Opin Support Palliat Care 2008; 2:110-113.
18. Smith J, Albert P, Bertella E, et al. Qualitative aspects of breathlessness in health and disease. Thorax 2009; 64:713-718.
19. Carrieri-Kohlman V, Donesky-Cuenco D, Park SK, et al. Additional evidence for the affective dimension of dyspnoea in patients with COPD. Res Nurs Health 2010; 33:4-19.
20. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnoea: review and hypotheses. Respir Physiol Neurobiol 2009; 167:53-60.
21. Williams M, Cafarella P, Olds T, et al. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest 2008; 134:489-496.
22. Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002; 57:939-944.
23. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003; 327:523-528.
24. Agle DP, Baum GL. Psychological aspects of chronic obstructive pulmonary disease. Med Clin North Am 1977; 61:749-758.
25. Greenberg GD, Ryan JJ, Bourlier PF. Psychological and neuropsychological aspects of COPD. Psychosomatics 1985; 26:29-33.
26. Simon NM, Weiss AM, Kradin R, et al. The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnoea-related distress and avoidance. J Nerv Ment Dis 2006; 194:951-957.
27. Smoller JW, Simon NM, Pollack MH, et al. Anxiety in patients with pulmonary disease: comorbidity and treatment. Semin Clin Neuropsychiatry 1999; 4:84-97.
28. Smoller JW, Otto MW. Panic, dyspnoea, and asthma. Curr Opin Pulm Med 1998; 4:40-45.
29. Smoller JW, Pollack MH, Otto MW, et al. Panic anxiety, dyspnoea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med 1996; 154:6-17.
30. Victorson DE, Anton S, Hamilton A, et al. A conceptual model of the experience of dyspnoea and functional limitations in chronic obstructive pulmonary disease. Value Health 2009; 12:1018-1025.
31. Kessler R, Stahl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest 2006; 130:133-142.
32. Gruffydd-Jones K, Langley-Johnson C, Dyer C, et al. What are the needs of patients following discharge from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD)? Prim Care Respir J 2007; 16:363-368.
33. Barnett M. Chronic obstructive pulmonary disease: a phenomenological study of patients' experiences. J Clin Nurs 2005; 14:805-812. (Pubitemid 41018436)
34. Guthrie SJ, Hill KM, Muers ME. Living with severe COPD. A qualitative exploration of the experience of patients in Leeds. Respir Med 2001; 95: 196.
35. Bailey PH. The dyspnoea-anxiety-dyspnoea cycle - COPD patients'stories of breathlessness: 'It's scary/when you can't breathe'. Qual Health Res 2004; 14:760-778.
36. Bailey PH. Death stories: acute exacerbations of chronic obstructive pulmonary disease. Qual Health Res 2001; 11:322-338.
37. von Leupoldt A, Sommer T, Kegat S, et al. Dyspnoea and pain share emotionrelated brain network. Neuroimage 2009; 48:200-206.
38. von Leupoldt A, Sommer T, Kegat S, et al. The unpleasantness of perceived dyspnoea is processed in the anterior insula and amygdala. Am J Respir Crit Care Med 2008; 177:1026-1032.
39. Peiffer C. Dyspnoea and emotion: what can we learn from functional brain imaging? Am J Respir Crit Care Med 2008; 177:937-939.
40. Leppa M, Korvenoja A, Carlson S, et al. Acute opioid effects on human brain as revealed by functional magnetic resonance imaging. Neuroimage 2006; 31:661-669.
41. Becerra L, Harter K, Gonzalez RG, Borsook D. Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers. Anesth Analg 2006; 103:208-216; table of contents.
42. Liberzon I, Zubieta JK, Fig LM, et al. mu-Opioid receptors and limbic responses to aversive emotional stimuli. Proc Natl Acad Sci U S A 2002; 99:7084-7089.
43. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific selfmanagement intervention. Arch Intern Med 2003; 163:585-591. (Pubitemid 36314346)
44. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122:823-832.